FirstLine

Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma

Phase 2 Study Evaluates Serplulimab Plus HLX04 as First-Line Treatment for Advanced Hepatocellular Carcinoma

admin January 13, 2025 0

An open-label, multicenter phase 2 study (NCT03973112) conducted in China aimed to investigate the safety and initial effectiveness of serplulimab...

Read More

ASCO24: BMS Eyes First-Line Treatment in Liver Cancer for Opdivo-Yervoy Combo

ASCO24: BMS Eyes First-Line Treatment in Liver Cancer for Opdivo-Yervoy Combo

admin June 5, 2024 0

Pictured: BMS sign on a building in San Diego, California/iStock, JHVEPhoto Bristol Myers Squibbs’ combination approach could become a first-line option...

Read More

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

Machine learning to predict immunotherapy treatment outcomes in liver cancer | Imperial News

admin May 18, 2025 0

AI in Liver Care Needs Vigilance and Tailoring to Population

AI in Liver Care Needs Vigilance and Tailoring to Population

admin May 16, 2025 0

Kidney Dialysis Equipment Market, In-Depth Analysis

Kidney Dialysis Equipment Market, In-Depth Analysis

admin May 16, 2025 0

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

KHSC expands liver cancer treatment with cutting-edge Y90 therapy

admin May 16, 2025 0

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

GSK to acquire efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of steatotic liver disease (SLD)

admin May 14, 2025 0